The Role of Treg Cells in the Cancer Immunological Response
Author(s) -
ZhiZhang Yang,
Stephen M. Ansell
Publication year - 2009
Publication title -
american journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1558-3775
pISSN - 1553-619X
DOI - 10.3844/ajisp.2009.17.28
Subject(s) - treg cell , immunology , cancer , antibody response , biology , immune system , genetics , t cell , il 2 receptor
Problem statement: T cell-mediated immunosuppression has been
observed for decades without clarification as to which factor was responsible
for this observation. The identification of CD4+CD25+ regulatory T (Treg) cells
represents a milestone in the filed of immunology and provides an explanation
for T-cell-mediated immunosuppression. Although Treg cells were originally identified
for their ability to prevent organ-specific autoimmune disease in mice, emerging
evidence suggests that Treg cells play a pivotal role in tumor immunity and contribute
to tumor growth and progression, thereby having an important impact on the outcome
of cancer patients. Approach: This article reviewed the medical
literature to describe how Treg cells affect anti-tumor immunity. Results:
Treg cells suppressed anti-tumor immunity by inhibiting the effector functions
of tumor-specific T cells and NK cells. Importantly, tumor cells played an active
role in recruiting and generating Treg cells and creating a suppressive tumor
microenvironment. Strategies to deplete Treg cells or inhibit their function had
yielded promising results by enhancing anti-tumor immunity in experimental studies
as well as clinical practice. Conclusion: A better understanding
of the pathophysiology of Treg cells not only increased our knowledge in a variety
of aspects of immunology but also potentially benefited cancer patients
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom